| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
6e-12 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
9e-12 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
8e-07 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |